Oligonucleotide therapeutics: A step forward

被引:41
作者
Gewirtz, AM [1 ]
机构
[1] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
关键词
D O I
10.1200/JCO.2000.18.9.1809
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1809 / 1811
页数:3
相关论文
共 38 条
[31]   Real time detection of DNA RNA hybridization in living cells [J].
Sokol, DL ;
Zhang, XL ;
Lu, PZ ;
Gewitz, AM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (20) :11538-11543
[32]   DOES ANTISENSE EXIST [J].
STEIN, CA .
NATURE MEDICINE, 1995, 1 (11) :1119-1121
[33]   INHIBITION OF ROUS-SARCOMA VIRAL-RNA TRANSLATION BY A SPECIFIC OLIGODEOXYRIBONUCLEOTIDE [J].
STEPHENSON, ML ;
ZAMECNIK, PC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (01) :285-288
[34]   Phase I/pharmacokinetic trial of the novel thioxanthone SR233377 (WIN33377) on a 5-day schedule [J].
Stevenson, JP ;
DeMaria, D ;
Reilly, D ;
Purvis, JD ;
Graham, MA ;
Lockwood, G ;
Drozd, M ;
O'Dwyer, PJ .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 44 (03) :228-234
[35]   RETROVIRUSES AND ONCOGENES-I [J].
VARMUS, HE .
BIOSCIENCE REPORTS, 1990, 10 (05) :413-430
[36]   Antisense technology and prospects for therapy of viral infections and cancer [J].
Wagner, RW ;
Flanagan, WM .
MOLECULAR MEDICINE TODAY, 1997, 3 (01) :31-38
[37]   Phase I clinical and pharmacokinetic study of Bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphoma [J].
Waters, JS ;
Webb, A ;
Cunningham, D ;
Clarke, PA ;
Raynaud, F ;
di Stefano, F ;
Cotter, FE .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (09) :1812-1823
[38]   PHARMACOKINETICS OF AN ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS ANTISENSE OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE (GEM-91) IN HIV-INFECTED SUBJECTS [J].
ZHANG, RW ;
YAN, JM ;
SHAHINIAN, H ;
AMIN, G ;
LU, ZH ;
LIU, TP ;
SAAG, MS ;
JIANG, ZW ;
TEMSAMANI, J ;
MARTIN, RR ;
SCHECHTER, PJ ;
AGRAWAL, S ;
DIASIO, RB .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 58 (01) :44-53